USD 0.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2021 | 5.34 Million USD | -8.74% |
2020 | 5.86 Million USD | 37.87% |
2019 | 4.25 Million USD | -86.08% |
2018 | 30.52 Million USD | 5.46% |
2017 | 28.94 Million USD | 200.63% |
2016 | 9.62 Million USD | 99.23% |
2015 | 4.83 Million USD | 93.32% |
2014 | 2.5 Million USD | -44.9% |
2013 | 4.53 Million USD | -43.97% |
2012 | 8.09 Million USD | 52.02% |
2011 | 5.32 Million USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | -100.0% |
2003 | 376 Thousand USD | -73.01% |
2002 | 1.39 Million USD | -56.6% |
2001 | 3.21 Million USD | -36.49% |
2000 | 5.05 Million USD | 73.92% |
1999 | 2.9 Million USD | 142.17% |
1998 | 1.2 Million USD | -69.23% |
1997 | 3.9 Million USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | -100.0% |
1992 | 500 Thousand USD | -61.54% |
1991 | 1.3 Million USD | 0.0% |
1990 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2022 Q1 | 5.51 Million USD | 3.18% |
2022 Q3 | 5.88 Million USD | 3.23% |
2022 Q2 | 5.69 Million USD | 3.23% |
2021 Q4 | 5.34 Million USD | 3.3% |
2021 FY | 5.34 Million USD | -8.74% |
2021 Q1 | 6.18 Million USD | 3.22% |
2021 Q2 | 5.01 Million USD | -18.93% |
2021 Q3 | 5.17 Million USD | 3.25% |
2020 Q1 | 4.38 Million USD | 3.22% |
2020 Q3 | 5.92 Million USD | 1.27% |
2020 Q2 | 5.84 Million USD | 33.3% |
2020 FY | 5.86 Million USD | 37.87% |
2020 Q4 | 5.99 Million USD | 1.18% |
2019 Q1 | 30.92 Million USD | 1.31% |
2019 Q4 | 4.25 Million USD | -86.7% |
2019 FY | 4.25 Million USD | -86.08% |
2019 Q2 | 31.51 Million USD | 1.91% |
2019 Q3 | 31.95 Million USD | 1.37% |
2018 Q2 | 29.72 Million USD | 1.33% |
2018 Q1 | 29.33 Million USD | 1.33% |
2018 FY | 30.52 Million USD | 5.46% |
2018 Q4 | 30.52 Million USD | 1.34% |
2018 Q3 | 30.12 Million USD | 1.35% |
2017 Q1 | 9.66 Million USD | 0.36% |
2017 FY | 28.94 Million USD | 200.63% |
2017 Q4 | 28.94 Million USD | 55.09% |
2017 Q3 | 18.66 Million USD | 1.48% |
2017 Q2 | 18.39 Million USD | 90.31% |
2016 Q1 | 4.19 Million USD | -13.26% |
2016 Q2 | 9.56 Million USD | 128.05% |
2016 Q3 | 9.59 Million USD | 0.37% |
2016 Q4 | 9.62 Million USD | 0.35% |
2016 FY | 9.62 Million USD | 99.23% |
2015 Q3 | 5 Million USD | 25.0% |
2015 FY | 4.83 Million USD | 93.32% |
2015 Q1 | 3.5 Million USD | 40.0% |
2015 Q4 | 4.83 Million USD | -3.34% |
2015 Q2 | 4 Million USD | 14.29% |
2014 Q4 | 2.5 Million USD | 69.86% |
2014 Q3 | 1.47 Million USD | -68.37% |
2014 Q2 | 4.65 Million USD | -5.12% |
2014 Q1 | 4.9 Million USD | 8.09% |
2014 FY | 2.5 Million USD | -44.9% |
2013 Q1 | 9.48 Million USD | 17.09% |
2013 Q3 | 5.79 Million USD | -1.06% |
2013 Q2 | 5.85 Million USD | -38.25% |
2013 FY | 4.53 Million USD | -43.97% |
2013 Q4 | 4.53 Million USD | -21.68% |
2012 Q1 | 8.5 Million USD | 59.56% |
2012 Q4 | 8.09 Million USD | -20.42% |
2012 Q3 | 10.17 Million USD | 14.08% |
2012 Q2 | 8.92 Million USD | 4.94% |
2012 FY | 8.09 Million USD | 52.02% |
2011 FY | 5.32 Million USD | 0.0% |
2011 Q4 | 5.32 Million USD | 2.32% |
2011 Q3 | 5.2 Million USD | -5.6% |
2011 Q2 | 5.51 Million USD | 1.17% |
2011 Q1 | 5.45 Million USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 Q3 | 510 Thousand USD | 226.92% |
2004 FY | - USD | -100.0% |
2004 Q1 | 260 Thousand USD | -30.85% |
2004 Q2 | 156 Thousand USD | -40.0% |
2004 Q4 | - USD | -100.0% |
2003 FY | 376 Thousand USD | -73.01% |
2003 Q4 | 376 Thousand USD | -37.75% |
2003 Q3 | 604 Thousand USD | 289.68% |
2003 Q2 | 155 Thousand USD | -85.63% |
2003 Q1 | 1.07 Million USD | -22.54% |
2002 Q2 | 2.2 Million USD | -14.17% |
2002 Q1 | 2.56 Million USD | -19.97% |
2002 FY | 1.39 Million USD | -56.6% |
2002 Q4 | 1.39 Million USD | -24.29% |
2002 Q3 | 1.84 Million USD | -16.55% |
2001 Q3 | 3.65 Million USD | -11.75% |
2001 Q2 | 4.13 Million USD | -10.05% |
2001 Q1 | 4.59 Million USD | -9.02% |
2001 FY | 3.21 Million USD | -36.49% |
2001 Q4 | 3.21 Million USD | -12.05% |
2000 Q4 | 5.05 Million USD | 5.69% |
2000 Q2 | 4.45 Million USD | 42.12% |
2000 Q1 | 3.13 Million USD | 7.91% |
2000 FY | 5.05 Million USD | 73.92% |
2000 Q3 | 4.78 Million USD | 7.29% |
1999 Q3 | 1.6 Million USD | -5.88% |
1999 FY | 2.9 Million USD | 142.17% |
1999 Q1 | 1.2 Million USD | 0.0% |
1999 Q2 | 1.7 Million USD | 41.67% |
1999 Q4 | 2.9 Million USD | 81.63% |
1998 Q2 | 4.7 Million USD | 4600.0% |
1998 Q4 | 1.2 Million USD | -68.42% |
1998 Q3 | 3.8 Million USD | -19.15% |
1998 Q1 | 100 Thousand USD | -97.44% |
1998 FY | 1.2 Million USD | -69.23% |
1997 Q2 | - USD | 0.0% |
1997 Q3 | 3.8 Million USD | 0.0% |
1997 Q4 | 3.9 Million USD | 2.63% |
1997 FY | 3.9 Million USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1993 Q2 | 500 Thousand USD | 0.0% |
1993 Q4 | - USD | -100.0% |
1993 Q3 | 500 Thousand USD | 0.0% |
1993 FY | - USD | -100.0% |
1993 Q1 | 500 Thousand USD | 0.0% |
1992 FY | 500 Thousand USD | -61.54% |
1992 Q3 | 500 Thousand USD | -44.44% |
1992 Q4 | 500 Thousand USD | 0.0% |
1992 Q2 | 900 Thousand USD | 0.0% |
1992 Q1 | 900 Thousand USD | -30.77% |
1991 FY | 1.3 Million USD | 0.0% |
1991 Q4 | 1.3 Million USD | 0.0% |
1990 FY | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alphatec Holdings, Inc. | 541.67 Million USD | 99.013% |
Nemaura Medical Inc. | 20.03 Million USD | 73.295% |
NeuroPace, Inc. | 72.39 Million USD | 92.611% |
LENSAR, Inc. | 2.3 Million USD | -131.659% |
Rapid Micro Biosystems, Inc. | 7.34 Million USD | 27.185% |
TriSalus Life Sciences, Inc. | 1.59 Million USD | -235.361% |
Apyx Medical Corporation | 38.5 Million USD | 86.107% |
Cutera, Inc. | 431.91 Million USD | 98.762% |
STRATA Skin Sciences, Inc. | 15.63 Million USD | 65.784% |
BioSig Technologies, Inc. | 452 Thousand USD | -1083.407% |
Accelerate Diagnostics, Inc. | 39.22 Million USD | 86.362% |
Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.682% |
Axonics, Inc. | 27.61 Million USD | 80.631% |
IRIDEX Corporation | 2.74 Million USD | -94.792% |
PROCEPT BioRobotics Corporation | 79.2 Million USD | 93.247% |
TELA Bio, Inc. | 42.78 Million USD | 87.496% |
Tivic Health Systems, Inc. | 369 Thousand USD | -1349.593% |
RxSight, Inc. | 3.01 Million USD | -77.59% |
Align Technology, Inc. | 96.96 Million USD | 94.484% |
INVO Bioscience, Inc. | 8.68 Million USD | 38.401% |
electroCore, Inc. | 626 Thousand USD | -754.473% |
Telesis Bio, Inc. | 34.38 Million USD | 84.442% |
Viemed Healthcare, Inc. | 10.27 Million USD | 47.922% |
Quipt Home Medical Corp. | 98.94 Million USD | 94.594% |
Anika Therapeutics, Inc. | 29.03 Million USD | 81.579% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -127.811% |
Lucid Diagnostics Inc. | 15.25 Million USD | 64.936% |
Dynatronics Corporation | 6.68 Million USD | 20.02% |
Modular Medical, Inc. | 1.19 Million USD | -349.496% |
ReShape Lifesciences Inc. | 262 Thousand USD | -1941.603% |
Talis Biomedical Corporation | 19.66 Million USD | 72.804% |
PetVivo Holdings, Inc. | 1.36 Million USD | -291.857% |
InMode Ltd. | 9.01 Million USD | 40.679% |
Envoy Medical, Inc. | 404 Thousand USD | -1224.01% |
Bruker Corporation | 1.37 Billion USD | 99.612% |
Helius Medical Technologies, Inc. | 57 Thousand USD | -9284.211% |
DexCom, Inc. | 2.59 Billion USD | 99.794% |
Nexalin Technology, Inc. | 4463.00 USD | -119752.117% |
PAVmed Inc | 48.72 Million USD | 89.022% |
Cerus Corporation | 95.99 Million USD | 94.428% |
Movano Inc. | 252 Thousand USD | -2022.619% |
Cytek Biosciences, Inc. | 33.17 Million USD | 83.876% |
Nexalin Technology, Inc. | 4463.00 USD | -119752.117% |
IceCure Medical Ltd | 599 Thousand USD | -792.988% |
Tandem Diabetes Care, Inc. | 415.66 Million USD | 98.713% |
enVVeno Medical Corporation | 1.4 Million USD | -281.526% |
908 Devices Inc. | 5.94 Million USD | 10.025% |
ClearPoint Neuro, Inc. | 13.94 Million USD | 61.631% |
Orthofix Medical Inc. | 134.19 Million USD | 96.014% |
Surmodics, Inc. | 29.4 Million USD | 81.809% |
Nuwellis, Inc. | 981 Thousand USD | -445.26% |
Outset Medical, Inc. | 136.18 Million USD | 96.072% |
Venus Concept Inc. | 79.69 Million USD | 93.288% |
iRhythm Technologies, Inc. | 129.82 Million USD | 95.88% |
Treace Medical Concepts, Inc. | 70.3 Million USD | 92.392% |
Nano-X Imaging Ltd. | 8.39 Million USD | 36.291% |
Aethlon Medical, Inc. | 940.31 Thousand USD | -468.851% |
Inogen, Inc. | 21.92 Million USD | 75.601% |
IRadimed Corporation | 2.04 Million USD | -161.815% |
MaxCyte, Inc. | 18.74 Million USD | 71.461% |
Pulmonx Corporation | 41.42 Million USD | 87.087% |
PAVmed Inc. | 48.72 Million USD | 89.022% |
iCAD, Inc. | 461 Thousand USD | -1060.304% |
OrthoPediatrics Corp. | 23.76 Million USD | 77.487% |
DIH Holding US, Inc. Warrants | 1.99 Million USD | -167.919% |
Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -987.215% |
NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -2800.759% |
SI-BONE, Inc. | 38.99 Million USD | 86.282% |
Semler Scientific, Inc. | 70 Thousand USD | -7541.429% |
Beyond Air, Inc. | 17.83 Million USD | 70.012% |
FONAR Corporation | 41.67 Million USD | 87.165% |
AxoGen, Inc. | 69.29 Million USD | 92.28% |
Biotricity, Inc. | 23.87 Million USD | 77.599% |
Cytosorbents Corporation | 18.31 Million USD | 70.791% |
ZimVie Inc. | 521.92 Million USD | 98.975% |
Tactile Systems Technology, Inc. | 50.37 Million USD | 89.382% |
Inari Medical, Inc. | 32.04 Million USD | 83.309% |
UFP Technologies, Inc. | 46.03 Million USD | 88.381% |
DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -167.919% |
QT Imaging Holdings, Inc. | 3.07 Million USD | -74.174% |
Sight Sciences, Inc. | 35.41 Million USD | 84.896% |
Insulet Corporation | 1.44 Billion USD | 99.631% |
Profound Medical Corp. | 7.9 Million USD | 32.294% |
Bioventus Inc. | 409.47 Million USD | 98.694% |
InspireMD, Inc. | 1.59 Million USD | -235.361% |
BrainsWay Ltd. | 471 Thousand USD | -1035.669% |
BIOLASE, Inc. | 17.91 Million USD | 70.134% |
Heart Test Laboratories, Inc. | 1.03 Million USD | -416.144% |
Tenon Medical, Inc. | 1.17 Million USD | -356.01% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | -433.832% |
CVRx, Inc. | 30.61 Million USD | 82.527% |
AdaptHealth Corp. | 2.29 Billion USD | 99.767% |
Sintx Technologies, Inc. | 4.24 Million USD | -26.007% |
Acutus Medical, Inc. | 38.47 Million USD | 86.099% |
Vivos Therapeutics, Inc. | 1.99 Million USD | -168.12% |
NanoVibronix, Inc. | 5000.00 USD | -106880.0% |
Quanterix Corporation | 41.46 Million USD | 87.1% |
LivaNova PLC | 640.4 Million USD | 99.165% |
Co-Diagnostics, Inc. | 2.99 Million USD | -78.862% |
Varex Imaging Corporation | 469.5 Million USD | 98.861% |
Vivani Medical, Inc. | 20.69 Million USD | 74.154% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -127.811% |
Sensus Healthcare, Inc. | 783 Thousand USD | -583.142% |
Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.427% |
TransMedics Group, Inc. | 515.94 Million USD | 98.963% |
ReWalk Robotics Ltd. | 1.9 Million USD | -181.083% |
NeuroMetrix, Inc. | 240.87 Thousand USD | -2120.645% |
Spectral AI, Inc. | 1.28 Million USD | -314.973% |
Hyperfine, Inc. | 185 Thousand USD | -2791.351% |
Establishment Labs Holdings Inc. | 192.22 Million USD | 97.217% |
Biomerica, Inc. | 785 Thousand USD | -581.401% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -1090.034% |
Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -1345.266% |
Silk Road Medical, Inc | 84.63 Million USD | 93.68% |